text.skipToContent text.skipToNavigation

{{ addToCartData.mixPtRmWarning }}

Desideri procedere?

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

Grazie

Risponderemo a breve alla tua richiesta.

Something went wrong, please try again later.

Ordine Veloce
In caso contrario, fai clic su "Annulla". Puoi anche salvare questo articolo per dopo.
Annulla

{{ favouriteItem.successMessage }}

Visualizza i preferiti.

Prodotto rimosso dai tuoi preferiti

{{ addToCartData.mixPtRmWarning }}

Desideri procedere?

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

Grazie

Risponderemo a breve alla tua richiesta.

Something went wrong, please try again later.

Product Overview

Codice prodotto

TRC-P319587

Numero CAS

265989-34-2

Formato del prodotto

Neat

Formula molecolare

C40H42D5FN2O5

Peso molecolare

659.84

Tipologia prodotto

Stable Isotope Labelled, API

CAS non marcato

125971-95-1

Informazioni sul prodotto

Nome dell'analita

(6-(2-[3-(4-Phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl)-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester

Numero CAS

265989-34-2

Formula molecolare

C40H42D5FN2O5

Peso molecolare

659.84

Massa accurata

659.3783

SMILES

[2H]c1c([2H])c([2H])c(c([2H])c1[2H])c2c(C(=O)Nc3ccccc3)c(C(C)C)n(CCC4CC(CC(=O)OC(C)(C)C)OC(C)(C)O4)c2c5ccc(F)cc5

InChI

InChI=1S/C40H47FN2O5/c1-26(2)36-35(38(45)42-30-16-12-9-13-17-30)34(27-14-10-8-11-15-27)37(28-18-20-29(41)21-19-28)43(36)23-22-31-24-32(47-40(6,7)46-31)25-33(44)48-39(3,4)5/h8-21,26,31-32H,22-25H2,1-7H3,(H,42,45)/i8D,10D,11D,14D,15D

IUPAC

tert-butyl 2-[6-[2-[2-(4-fluorophenyl)-3-(2,3,4,5,6-pentadeuteriophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate

CAS non marcato

125971-95-1

Tipologia SIL

Deuterium

Temperatura di spedizione

Room Temperature

Paese di origine

CANADA

Tipologia prodotto

Stable Isotope Labelled; API

Formato del prodotto

Neat

An deuterated intermediate of deuterated Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.

References: Kearney, A.S., et al.: Pharm. Res., 10, 1461 (1993), Heinonen, T.M., et al.: Clin. Ther., 18. 853 (1996), Whitfield, L.R., et al.: Eur. J. Drug Metab. Pharmacokinet., 25, 97 (2000)

Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.